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Recombinant retroviral vector containing human tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) 
gene was constructed and investigation of the in vitro invasion and metastasis of gastric cancer cells 
transfected with TIMP-2 was carried out. Human TlMP-2 was isolated from recombinant vector Bluescript 
1/TIMP-2(+), and then inserted into the retroviral vector pL-MT. Correct orientation was verified by 
restriction endonuclease digestion. Human full length TIMP-2 gene was ligated into a plasmid, which 
was then transfected into PA317 cell line. G418-resistant individual clones were selected to transfect 
human SGC-7901 cell line. Cell proliferation, cell electrophoresis, soft agar colony formation and in vitro 
invasion were detected to analyze the bio-behavioral changes of cancer cells. The results from 
restriction endonuclease digestion were as theoretically expected. The cell electrophoresis rate, colony 
number and invasion ability in SGC-7901 cells and MFC cells transfected with TIMP-2 gene were 
significantly decreased when compared with control group. However, no significant changes were noted 
in the proliferation of cancer cells. We successfully construct a recombinant retroviral vector containing 
human TIMP-2. TIMP-2 transfection could markedly alter the membrane charge of cancer cells, resulting 
in decreased electrophoresis capacity, cell migration and invasion. However, cell growth was not 
affected by TIMP-2. These results suggested TIMP-2 transfection might exert effects on the malignant 
phenotype of cancer cells through affecting extracellular environment, which provided a new way to 
investigate gene regulation of in vitro collagen metabolism.  
 






The molecular mechanisms underlying the invasion and 
metastasis of cancer cells have been a hot topic in cancer 
research (Declereck et al., 1992). Numerous studies have 
indicated that tissue inhibitor of matrix metalloproteinases 
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matrix through affecting the degradation of metallo- 
proteinases (MMPs) and can reverse the malignant 
phenotype of some types of cancer cells (Koyama, 2005; 
Shih et al., 2009). However, few studies have been 
conducted to directly investigate the effects of TIMPs on 
cancer cell migration. Recently, more attention has been 
paid to the transfection of TIMPs into cancer cells leading 
to increased expression of TIMPs, which may regulate the 
metabolism of extracellular matrix and affect invasion 
capability of cancer cells. In the present study, a recom- 
binant retroviral vector containing the human TIMP-2 
gene was constructed and transfected into human cancer 
cell line (SGC-7901). In vitro construction of human 
full-length TIMP-2 gene was  performed  and,  through   




lipofectin transfection, TIMP-2 was transfected into 
human gastric cancer cells (SGC-7901) and mouse 
forestomach carcinoma (MFC) cell line. Cell proliferation, 
cell electrophoresis, soft agar colony formation assay and 
in vitro invasion assay were performed to evaluate the 
effects of TIMP-2 transfection on the malignant phenotype 
of these cells 
 
 




The recombinant retroviral vector containing NeoR gene was 
provided by Prof. Beifeng Shen, Institute of Basic Medical Sciences, 
Academy of Military Medical Science, China. BIuescriptl/TIMP-2(+) 
plasmid containing human full-length TIMP-2 gene (EcoRl/Xbal) was 
kindly provided by Dr. Stetler-Stevenson, National Cancer Institute, 
USA. DNA purification kit was purchased from Promega, USA. 
Competent Escherichia coli strain DH5a and hb101 were prepared 
using CaCl2. The restriction endonucleases and other reagents were 
commercial products. Human SGC-7901 cell line was from Institute 
of Digestive Diseases, Xijing Hospital, the Fourth Military Medical 
University, China. MFC cell line was provided by Dr. Jin Gao, 
Chinese Academy of Medical Sciences, China. PA317 cell line and 
NIH3T3 cell line were provided by Institute of Basic Medical 
Sciences, Academy of Military Medical Science, China. Boyden 
Chamber was modified and provided by Dr. Jin Gao, Chinese 
Academy of Medical Sciences. Polycarbonate membrane with a 
pore size of 12 m and a filter size of 13 mm was purchased from 
Proctiches, USA. Matrigel was provided by Cell Biology Laboratory, 





In vitro cell growth curve and doubling time  
 
The cells were seeded in a 74-well plate at a density of 1 × 106/ml 
and maintained in an incubator. Cell counting was performed every 
24 h. Four samples were included in each group and experiment 
was performed in triplicates. About 2 l of 3-(4,5-Dimethylthiazol- 
2-yl)-2,5- diphenyltetrazolium bromide, a tetrazole (MTT) was added 
into each well, followed by incubation for 4 h. Approximately 1 ml of 
supernatant was removed and 0.1 ml of lysis buffer (20% SDS, 
5%DMSDD; pH 7.4) was supplemented followed by incubation 
overnight at 37°C. The optical density (OD) was detected at 570 nm 
using a microplate reader (El309, USA). The degree of dilution 
under which the OD value was half of the maximum OD value was 
considered as the end point of titration.  
 
 
Soft-agar colony formation assay  
 
The medium was mixed with 0.7% agarose followed by sterilization. 
Then, the mixture was cooled to 50°C and supplemented with 
Roswell Park Memorial Institute (RPMI) 1640 medium containing 
20% fetal calf serum of equal volume. The underlay of plate was 
added with 2 ml of mixture followed by solidification. Then, 1 ml of 
0.3% soft-agar medium containing cells (50, 100, 300 or 500 cells) 
was added followed by incubation in a 37°C incubator with 5% CO2 
for 7 days. Experiment was performed in quintuplicates. The number 
of foci was counted under a microscope followed by averaging.  
 
 
Cell electrophoresis  
 





with trypsin and then loaded onto Mark II automatic electrophoresis 
apparatus for electrophoresis. This experiment was performed with 
the assistant of Beijing Anzhen Hospital. 
 
 
Cell migration assay 
 
NIH3T3 cells were maintained in serum free medium for 24 h. The 
supernatant was obtained and placed in the lower chamber. The 
upper chamber and lower chamber was separated by polycarbonate 
filters (pore size: 12 m; filter size: 13 m), on which Matrigel 
(artificial basement membrane, type IV collagen, laminin, etc) was 
put (Tondreau et al., 2009; Takahia et al., 1995). The cells with 
designed density were placed into the upper chamber. The chamber 
was incubated at 37°C and 5% CO2 for 6 h. The filters were then 
removed, and the cells on the upper side of the filter were scraped 
off with a cotton-tipped swab. Cells that migrated to the lower side of 
the filter were fixed in situ in methanol and stained with hematoxylin. 
Five randomly chosen fields were examined for cell density at 200× 
magnification with a phase-contrast microscope (Leica). Experiments 
were performed in duplicate and repeated at least four times.  
 
 
Statistical analysis  
 
Results were expressed as the means ± standard deviation. 
Comparison of means was performed using one-way analysis of 
variance followed by Dumentt test. A value of P < 0.05 was 





Synthesis of gene fragment of TIMP-2 signal peptide 
 
Single strand DNAs of 60 or 45 bp were synthesized 
using an automatic DNA synthesizer. Restriction 
endonuclease EcoR I/Pst I sites were included at the end 
of DNA and a complementary region of 15 bp was 
observed at the center of the single DNAs. After annealing 
and primer extension with Klenow polymerase, 
electrophoresis was performed and a signal peptide with 
87 bp in length was identified.  
 
 
Subcloning of TIMP-2 signal peptide into pGEM-4Z 
vector 
 
The pGEM-4Z vector was digested with cohesive 
end-producing restriction endonucleases (EcoR I and Pst 
I) followed by ligation with signal peptides containing 
restriction endonuclease EcoR I/Pst I sites with T4 DNA 
ligase. Correct orientation was verified by restriction endo- 
nuclease digestion.  
 
 
Subcloning of TIMP-2 into pGEM-4Z vector containing 
signal peptide 
 
The Bluescript/TIMP-2 plasmid was digested with PSt I, 
and TIMP-2 cDNA with Bluescript I multiple cloning site 
and restriction endonuclease Pst I site was obtained. The 
pGEM-4Z vector containing TIMP-2 signal  peptide  was  










prepared by digestion with restriction endonuclease Pst I 
and non-directional ligation was performed between 
TIMP-2 cDNA and pGEM-4Z vector. Correct orientation 
was verified by restriction endonuclease digestion. DNA 
sequencing was performed in pGEM-4Z vector containing 
human full length TIMP-2 gene to confirm the correct 
sequences of exogenous fragment and signal peptide 
(Figure 1).  
 
 
Subcloning of human full length TIMP-2 and its signal 
peptide into the pLXSN retroviral vector 
 
After confirmation of correct orientation, plasmid 
amplification and purification were performed. The MT-1 
promoter in pXMT vector was digested with restriction 
endonuclease Ecor I and BgII followed by recovery. The 
products were subcloned into endonuclease EcoR I site in 
pLXSN-TIMP-2 vector. Correct orientation was verified by 
restriction endonuclease digestion and the TIMP-2 cDNA 
retroviral vector containing MT-1 promoter was obtained 
(Figure 2).  
 
 
Growth curve of cells transfected with TIMP-2 gene  
 
The cell growth of SGC-7901 cells and MFC cells with 
and without transfection of TIMP-2 was determined. The 
growth of cells transfected with TIMP-2 was markedly 
slowed with prolonged time of culture. It could clearly  be  










seen that, for both MFC and SGC-7901, the growth of 
cells with and without TIMP-2 were significantly different. 
These results implied that the TIMP-2 transfection might 
affect cancer cell growth (Figure 3).  
 
 
Cell electrophoresis rate 
 
The cell migration velocity was determined by the amount 
of surface changes. Therefore, the cell electrophoresis 
rate could represent the cell migration velocity to a certain 
extent. The cell line with high invasive potential and high 
migration had a relatively high electrophoresis rate. The 
cancer cells transfected with TIMP-2 had a significantly 
lowered electrophoresis rate compared to those without 
transfection of TIMP-2. These results suggest that surface 
charges of cancer cells transfected with TIMP-2 gene 
were altered. Significant difference in the cell 
electrophoresis rate was observed between cells with and 
without TIMP-2 transfection (Table 1).    
 
 
Soft-agar colony formation  
 
The number of foci in the SGC-7901B was markedly 
higher than the other two groups. The SGC-7901B clone 
had a vigorous growth and clustered colonies could be 
observed after 5 - 7 days of culture. The number and size 
of colonies in SGC-7901B clone were dramatically larger 
than those in the other two groups (Table 2).  
 
 
Cell migration  
 
In vitro reconstituted basement membrane invasion assay 
was employed to determine if TIMP-2 expression affected 
cancer cell invasion. As shown in Table 3, after 6 h of 
incubation, cancer cells with different numbers could be 
observed on the back of polycarbonate filter. As for MFC, 
its invasion was fairly strong, so the MFC transfected with 
TIMP-2 tended to be readily inhibited. On the contrary, the 
invasion of SGC-7901 was moderate, so the number of 






In recent years, numerous studies have found that cancer 
metastasis is closely related with proteases (Wu  et  al.,  










Table 1. Cell electrophoresis rate in difference cell lines. 
 
Group Number of cells (0.1×106) Cell electrophoresis rate P value 
MFC 1.0 1.87 < 0.01 
MFC-T2 1.0 0.81* - 
SGC-7901 1.0 1.33 - 
SGC-7901-T2 1.0 1.03** < 0.05 
 




Table 2. Number of foci in different cell lines transfected with TIMP-2. 
 
Cell line Number of cells 
Number of foci/ plate 
mean P value 
1 2 3 4 5 
MFC 0.1 × 106 77 79 65 66 56 69.2 - 
MFC-T2 0.1 × 106 77 38 29 40 31 35.0* < 0.05 
SGC-7901 0.1 × 106 48 32 43 37 42 41.8 - 
SGC-7901-T2 0.1 × 106 15 18 19 18 6 18.8** < 0.01 
 




2007; Sadatmansoori et al., 2001), in which the MMPs 
secreted by cancer cells play an important role in cancer 
metastasis through destroying the integrity of basement 
membrane (Shiomi and Okada, 2003). Several types of 
TIMPs have been found in human being. TIMPs can bind 
some MMPs including collagenase resulting in the 
inactivation of these MMPs, which protects the integrity of 
basement membrane. Since the discovery of TIMP-2 in 
1989, transfection with TIMP-2 has been performed in 
several types of cells. Results showed TIMP-2 
transfection could, at least partly, suppress the malignant 
phenotype of some cancers (Grignon et al., 1996; Imai et 
al., 1996; Tsuchiya et al., 1993). However, no study has 
been con- ducted to explore the effects of TIMP-2 on 
cancer metastasis and the mechanisms.  
In the present study, the pL-MT-2 retroviral vector was 
constructed. In this vector, the virus structure was 
removed and long terminal repeats (LTR) were preserved 
in which gene transcription was driven by 5'-LTR 
promoter. In addition, this vector also included the SV40 
promoter which controlled the transcription of NeoR gene. 
In the construction of the viral vector, restriction 
endonuclease EcoR I site and EcoR I/BgL-1 sites in MT-1 
promoter were modified, which were then ligated with 
human MT-1 promoter. Because MT-1 is sensitive to 
heavy metal ions, the protein could be  express  in  an  




Table 3. Cell invasion of different cell lines. 
 
Group Time to invasion (h) Number of cells (1 × 106) Cell density (cells) 
MFC 6 2 73.09 ± 11.66 
MFC-T2 6 2 52.80 ± 12.54* 
SGC-7901 6 2 33.50 ± 10.67 
SGC-7901-T2 6 2 31.47 ± 11.15 
 




environment with heavy metal ions including zinc (Zn) and 
chromium (Cr) (Unger et al., 1999). The human full length 
TIMP-2 gene was correctly inserted into restriction 
endonuclease EcoR I/BamH-I sites in pGEM-4Z vector. 
Because the multiple cloning site EcoR I in the pL-MT was 
occupied by MT-1 promoter, the Pst I/BamH I sites in the 
pGEM-4Z-TIMP-2 vector and XhoL I/BamH I multiple 
cloning sites in the pL-MT were initially modified followed 
by ligation. The recombinant vector was verified by 
restriction endonuclease digestion (Nawrocki-Raby et al., 
2003). 
As shown in Figure 1, one Hind site and two Hindl sites 
were found in pL-MT vector. Among these sites, one Hindl 
site was 300 bp away from the multiple cloning sites. The 
two Hindl sites and the exogenous fragment with different 
length were used to verify the insert orientation. MT-1 
promoter was inserted into the upstream of TIMP-2 gene 
and theoretically, the nearest promoter may exert stronger 
regulatory effects when multiple promoters have been 
inserted (Miyagi et al., 2007). In the present study, we 
attempted to make the MT-1 promoter in the pL-MT vector 
exert regulatory effects on the expression of TIMP-2. In 
the construction of signal peptide, the long fragment (87 
bp) made the synthesis difficult at one time accompanied 
by non-specific errors. Based on the aptamer theory, two 
single stranded DNAs were generated with 60 and 45 bp 
in length, and these two DNAs had a complementary end 
with 15 bp in length. After annealing and extension with 
Klenow polymerase, a signal peptide of 87 bp was 
obtained as expected.  
In this study, the correct orientation in the plasmid was 
verified and the construction of recombinant vector was 
done with quadruplicate subcloning. The first was to 
screen the recombinant containing pGEM-4Z-TIMP-2 
signal peptide. In the subcloning, restriction endonuclease 
EcoR I/Pst I sites were used and fragments with about 90 
and 270 bp in length were observed which verify the 
correct orientation. The second was to screen pGEM-4E-T2 
recombinant. Since the restriction endonuclease EcoR 
I/Pst I sites in the pGEM-4E vector were inserted with 
signal peptide, the TIMP-2 gene was inserted at Pst I site 
and ligated with signal peptide. Restriction endonuclease 
digestion disclosed the Pst I site at the 5’ end of TIMP-2 
gene was correctly ligated to the Pst I (Ali et al., 1994). 
The third was to screen PL-MT-T2 recombinant. Since the 
MT-1 promoter must be inserted at the upstream of 
TIMP-2, the EcoR I site should be occupied by multiple 
cloning site. The vector underwent non-specific digestion 
and end screening followed by ligation with TIMP-2 gene. 
Correct orientation was confirmed by restriction endo- 
nuclease digestion. Therefore, a retroviral vector 
containing MT-1 promoter and TIMP-2 gene was 
successfully constructed. To investigate the in vitro and in 
vivo expression of TIMP-2 gene in retroviral vector, lipofectin 
transfection was performed to infect PA 317 cells. After 
screening with G418, NIH 3T3 cells with positive 
expression of TIMP-2 were selected to obtain the 
infectionable recombinant. Then, the TIMP-2 was trans- 
fected into gastric cancer cells followed by detection of 
malignant phenotype of cancer cells. The results showed 
the cancer cells had altered membrane charge after 
TIMP-2 transfection accompanied by decreased cell 
electrophoresis rate. In addition, soft-agar colony forma- 
tion assay indicated reduced number of foci after TIMP-2 
transfection. However, the cell growth was not 
significantly affected. These findings suggested that cell 
proliferation was not influenced by TIMP-2, and TIMP-2 
transfection might alter the membrane charge as well as 
the interactions between cancer cells and matrix (Xia et 
al., 2005; Nie et al., 1999).  
The cell migration assay confirmed the results above 
(Chang et al., 2006). Currently, Boyden chamber method 
is the best way to detect the cancer cell invasion. In this 
model, Matrigel contains some main components of 
human basement membrane including type IV collagen 
and laminin. The migration of cancer cells on the Matrigel 
involves adhesion, degradation and movement. To 
penetrate through the basement membrane, morphological 
changes of cancer cells and secretion of proteinases are 
necessary (Ebert et al., 2005; Xia et al., 2007). The 
secreted proteinases can degrade extracellular matrix 
promoting cell migration. Previous studies indicated that 
normal cells seldom penetrated the Matrigel containing 
type IV collagen and other matrix, but increased pene- 
trability was observed in cancer cells with high metastasis 
(Li et al., 2002; Caudroy et al., 2002). Our results 
indicated significant difference in the penetrability which 
was found between the cell lines (GC-7901 and MFC) 
with and without TIMP-2 transfection. Previous study 
postulated that soft agar colony formation assay was the 
only way to detect the biological activity of cancer cells. 
According to our findings, the proliferation of cancer cells 
transfected with TIMP-2 was not markedly affected, which 





formation assay. Sometimes, soft agar colony formation 
assay was also found to have unacceptable repeatability. 
The difficulties underlying the soft agar colony formation 
assay are resolved by Boyden Chamber assay which has 
been found to have high accuracy and acceptable 
repeatability. Therefore, we recommend Boyden Chamber 
assay in the detection of metastasis and/or invasion of 
cancer cells.  
In the present study, the retroviral vector containing human 
full length TIMP-2 gene was successfully generated. Our 
results showed caner cells transfected with TIMP-2 had 
altered membrane charge resulting in decreased cell 
electrophoresis rate, reduced migration and alleviated 
penetrability. However, cell proliferation was not affected 
by TIMP-2 transfection. These findings suggested that 
through affecting extracellular environment, TIMP-2 might 
exert effects on the malignant phenotype of cancer cells, 
which provided a new way to investigate gene regulation 
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